1.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198

2.
Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
by Hwang, Jin Ho
American journal of nephrology, 2016-12, Vol.44 (6), p.481-492

3.
Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria
by Tang, Xiaojing
American journal of nephrology, 2014-06, Vol.39 (5), p.376-382

4.
Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease
by Nakamura, Tsukasa
The American journal of the medical sciences, 2007-06, Vol.333 (6), p.321-326

5.
Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease
by Lee, Yu-Ji
Postgraduate medical journal, 2011-10, Vol.87 (1032), p.664-669

6.
Effect of Erythropoietin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Chronic Renal Failure and Anemia
by Nakamura, Tsukasa
American journal of nephrology, 2006-07, Vol.26 (3), p.276-280

7.
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
by SNOECK, E
Psychopharmacologia, 1995, Vol.122 (3), p.223-229

8.
Effect of enalapril on the progression of chronic renal failure : a randomized controlled trial
by KAMPER, A.-L
American journal of hypertension, 1992, Vol.5 (7), p.423-430

9.
A Chinese adult onset type II citrullinaemia patient with 851del4/1638ins23 mutations in the SLC25A13 gene
by Hwu, W L
Journal of medical genetics, 2001-07, Vol.38 (7), p.E23-23

10.
Early detection of heart transplant patients with increased risk of ciclosporin nephrotoxicity
by Câmara, Niels Olsen Saraiva
The Lancet (British edition), 2001-03-17, Vol.357 (9259), p.856-857

11.
Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure
by DAE-YEOL LEE
The journal of clinical endocrinology and metabolism, 1994, Vol.79 (5), p.1376-1382

12.
Human bladder urine oxygen content: implications for urinary tract diseases
by Giannakopoulos, X
International urology and nephrology, 1997, Vol.29 (4), p.393-401

13.
An evaluation of the influence of therapeutic interventions on serum trace element levels in groups of patients
by Senft, Václav
Journal of trace elements in medicine and biology, 2003, Vol.17 (1), p.7-11

14.
Residual renal function in children on haemodialysis and peritoneal dialysis therapy
by FEBER, J
Pediatric nephrology (Berlin, West), 1994, Vol.8 (5), p.579-583

15.
Urinary cAMP activity in chronic renal failure
by Mocan, M Z
International urology and nephrology, 1998, Vol.30 (2), p.215-221

16.
The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate
by KNAUF, H
European journal of clinical pharmacology, 1994, Vol.46 (1), p.9-13

17.
Urinary growth hormone levels measured by ultrasensitive enzyme immunoassay in patients with renal insufficiency
by HATTORI, N
The journal of clinical endocrinology and metabolism, 1988, Vol.66 (4), p.727-732

18.
Urinary caffeine metabolites in man : age-dependent changes and pattern in various clinical situations
by ULLRICH, D
European journal of clinical pharmacology, 1992, Vol.43 (2), p.167-172

19.
Role of Urinary Arginine Vasopressin in the Sodium Excretion in Patients With Chronic Renal Failure
by Nonoguchi, Hiroshi
The American journal of the medical sciences, 1996-11, Vol.312 (5), p.195-201

20.
Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours
by KNAUF, H
European journal of clinical pharmacology, 1992, Vol.43 (1), p.23-27
